Homer, while I understand what you are saying here, what I do not understand and maybe someone can explain it to me, is why Dawson James can provide us with information concerning the IPO, but they cannot provide Generex / NGIO with the same information that can then be shared with us. If DJ says to a shareholder blah, blah blah, why cant they tell Management that same info and it be passed to the shareholders? Or why cant attorneys for both companies get together and write up something that can be shared so it comes from one source to everyone, instead of telling everyone to call Dawson James. That was my point in all of this. I get what Joe said that they can't talk about something if the SEC says so. But if DJ is allowed to say something to a shareholder, then are they allowed to tell the company something which can be told back to shareholders or can they be on a call to tell the shareholders?
Concerning everything else, it looks like Generex / NGIO is moving in the right direction and everything is actually more along on all fronts than most people actually thought.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links